These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 8607394)

  • 21. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
    J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias].
    Maison-Blanche P; Brembilla-Perrot B; Fauchier JP; Babuty D; Garnier LF; Rouesnel P; Breuillac JC; Funck F; Scheck F; Peraudeau P; Medvedowsky JL
    Ann Cardiol Angeiol (Paris); 1997 Feb; 46(2):109-16. PubMed ID: 9137677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ
    Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical cardioversion of atrial fibrillation and flutter with class IC antiarrhythmic drugs in young patients with and without congenital heart disease.
    Przybylski R; Eberly LM; Alexander ME; Bezzerides VJ; DeWitt ES; Dionne A; Mah DY; Triedman JK; Walsh EP; O'Leary ET
    J Cardiovasc Electrophysiol; 2023 Dec; 34(12):2545-2551. PubMed ID: 37846208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group.
    Podrid PJ; Anderson JL
    Am J Cardiol; 1996 Aug; 78(4):430-4. PubMed ID: 8752188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effectiveness and side effects of the treatment with propafenone and flecainide for recent-onset atrial fibrillation].
    Romano S; Fattore L; Toscano G; Corsini F; Coppo A; Catanzaro M; Romano A; Martone A; Caccavale F; Iodice E; Di Maggio O; Corsini G
    Ital Heart J Suppl; 2001 Jan; 2(1):41-5. PubMed ID: 11216083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation.
    Lee SH; Chen SA; Tai CT; Chiang CE; Wen ZC; Chen YJ; Yu WC; Huang JL; Fong AN; Cheng JJ; Chang MS
    Am J Cardiol; 1997 Apr; 79(7):905-8. PubMed ID: 9104904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cibenzoline versus flecainide in the prevention of paroxysmal atrial arrhythmias: a double-blind randomized study.
    Babuty D; D'Hautefeuille B; Scheck F; Mycinsky C; Pruvost P; Peraudeau P
    J Clin Pharmacol; 1995 May; 35(5):471-7. PubMed ID: 7657846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study).
    Meinertz T; Lip GY; Lombardi F; Sadowski ZP; Kalsch B; Camez A; Hewkin A; Eberle S;
    Am J Cardiol; 2002 Dec; 90(12):1300-6. PubMed ID: 12480038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Persistent atrial flutter induced by propafenone (Rytmonorm)].
    Fazekas T; Kiss J; Pap I; Rudas L
    Orv Hetil; 1994 Aug; 135(33):1819-22. PubMed ID: 8072758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation.
    Stabile G; De Simone A; Turco P; La Rocca V; Nocerino P; Astarita C; Maresca F; De Matteis C; Di Napoli T; Stabile E; Vitale DF
    J Am Coll Cardiol; 2001 May; 37(6):1639-44. PubMed ID: 11345378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols.
    Boriani G; Biffi M; Capucci A; Botto G; Broffoni T; Ongari M; Trisolino G; Rubino I; Sanguinetti M; Branzi A; Magnani B
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2470-4. PubMed ID: 9825369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different clinical courses and predictors of atrial fibrillation occurrence after transisthmic ablation in patients with preablation lone atrial flutter, coexistent atrial fibrillation, and drug induced atrial flutter.
    Bertaglia E; Bonso A; Zoppo F; Proclemer A; Verlato R; Corò L; Mantovan R; Themistoclakis S; Raviele A; Pascotto P;
    Pacing Clin Electrophysiol; 2004 Nov; 27(11):1507-12. PubMed ID: 15546305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of propafenone for recurrent paroxysmal atrial fibrillation.
    Connolly SJ; Hoffert DL
    Am J Cardiol; 1989 Apr; 63(12):817-9. PubMed ID: 2648787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and safety of intravenous propafenone versus intravenous amiodarone in the conversion of atrial fibrillation or flutter after cardiac surgery.
    Larbuisson R; Venneman I; Stiels B
    J Cardiothorac Vasc Anesth; 1996 Feb; 10(2):229-34. PubMed ID: 8850403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results of hybrid therapy in patients with atrial fibrillation who develop atrial flutter during flecainide infusion.
    Turco P; De Simone A; La Rocca V; El Jamal B; Nocerino P; Astarita C; De Matteis C; Messina V; Greco L; Rotunno R; Di Napoli T; Vitale DF; Stabile G
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S124-7. PubMed ID: 15683478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacogenetic study of the response to flecainide and propafenone in patients with atrial fibrillation].
    Martínez-Sellés M; Castillo I; Montenegro P; Martín ML; Almendral J; Sanjurjo M
    Rev Esp Cardiol; 2005 Jun; 58(6):745-8. PubMed ID: 15970126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
    Dorian P; Naccarelli GV; Coumel P; Hohnloser SH; Maser MJ
    Am J Cardiol; 1996 Jan; 77(3):89A-95A. PubMed ID: 8607397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs.
    Antman EM; Beamer AD; Cantillon C; McGowan N; Friedman PL
    J Am Coll Cardiol; 1990 Mar; 15(3):698-707. PubMed ID: 2303641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group.
    Pritchett EL; DaTorre SD; Platt ML; McCarville SE; Hougham AJ
    J Am Coll Cardiol; 1991 Feb; 17(2):297-303. PubMed ID: 1899432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.